| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90bdd3287688eb3c00e3b10a6877fb97 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C259-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C239-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-64 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C259-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-34 |
| filingDate |
2007-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_373b5a26b189d8a4e60c5cd152122ca7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6090a30de6c1c933336b3df06681cf7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aa8311242b8f9a3b8025cdfed7d1f5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecba211beb98ca89880d7c15b82c0bed |
| publicationDate |
2008-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008033024-A1 |
| titleOfInvention |
Aryl amino acid derivatives as inhibitors for treating inflammation |
| abstract |
The present invention relates to a chemical genus of 3-(triaryl)-2-aminopropanol derivative inhibitors of LTA4H (leukotriene A4 hydrolase) useful for the treatment and prevention of inflammatory diseases and disorders. The compounds have general formula III: n n nA particular embodiment is |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9617197-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011077427-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385007-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103396346-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020500899-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8476305-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7174700-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013236532-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018107158-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102099331-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014523887-A |
| priorityDate |
2006-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |